MK-677 — Benefits & User Experiences
Ibutamoren — orally active growth hormone secretagogue that mimics ghrelin. Stimulates pituitary GH and IGF-1 release without injection.
Also known as:
often mentioned with:
Related topics
community guides:
MK-677 occupies a unique position in the community: it is the only widely used GH secretagogue that does not require injection. This makes it the entry point for many users who want GH benefits without needles, and it appears in more accounts from less experienced peptide users than almost any other GH compound. The community's accumulated knowledge about MK-677 is detailed — covering what works, what the side effects actually look like at real doses, and the gap between online hype and confessional honesty.
What MK-677 Is and How It Works
MK-677 (ibutamoren) is an oral, non-peptide ghrelin-receptor (GHS-R1a) agonist that stimulates GH and IGF-1 release. It has a long half-life, so effects are sustained. Mimicking ghrelin also explains its best-known side effect: hunger. It is not a SARM and does not act on androgen receptors. It is not approved as a medicine, and WADA prohibits it.
What the Community Reports from MK-677
Sleep improvement is the most immediately reported benefit in community MK-677 accounts — often described within the first week of use. Accounts describe deeper sleep, more vivid dreams (attributed to the GH pulse during early sleep), and waking feeling more rested. Body composition improvements describe a familiar arc: the first 4–8 weeks are dominated by water retention and increased hunger; by months 2–3 accounts describe lean mass retention improving and fat accumulation slowing; at months 3–6 meaningful recomposition becomes visible. The community is clear that MK-677 produces body composition benefits over months, not weeks. Accounts that focus on MK-677 for muscle growth describe it as a supporting compound rather than a primary anabolic — the gains are described as gradual and sustainable rather than dramatic.
Side Effects — The Honest Community Account
Water retention, especially morning facial puffiness, is the most common complaint in reports, often easing over weeks. Hunger is near-universal. Clinical studies show raised fasting glucose and reduced insulin sensitivity, and a trial in older adults was stopped early over heart-failure concerns. Joint pain and tingling appear too. Reports consistently describe side effects as worse at higher amounts.
Why This Page Publishes No MK-677 Dose
This site does not publish MK-677 doses or timing. It is not an approved medicine, so there is no validated dose, and unapproved products vary. The pattern in reports: many describe a better experience after reducing the amount they took, with fewer side effects and similar sleep effects. Anyone with diabetes, prediabetes or heart failure risk should not experiment with it.
Long-Term Use — Community Perspectives
Long continuous use is discussed openly in reports. The concerns are sustained IGF-1 elevation (linked in epidemiology to some cancers) and insulin resistance — reports describe fasting glucose creeping up over months. Reports that take this seriously describe bloodwork for glucose and IGF-1 with a clinician, and breaks. There are no long-term human safety studies.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
No reports found.
Community Q&A
- How long does MK-677 stay in your system?
- Community accounts point to a 24-hour half-life, which is why its GH and IGF-1 effects are sustained rather than pulsed. The most noticeable effects — hunger and water retention — typically fade within 2–3 days of stopping. Discussions about drug testing reference detection windows of several days to weeks depending on the assay, though most of these are anecdotal rather than confirmed by lab results.
- Does MK-677 cause water retention?
- Water retention appears in the majority of early MK-677 accounts and is cited as the most common initial side effect. Community reports describe puffiness around the face and extremities, most pronounced in the first 4–8 weeks. A subset of accounts describe it resolving at stable dosing; others report it persists for the duration of use. Some accounts describe changing how much they used when puffiness bothered them. This site does not publish dosing guidance.
- When is the best time to take MK-677?
- Many accounts prefer evening use because hunger is harder to manage during the day. This site does not publish timing or dosing guidance.
- What is MK-677?
- MK-677 (ibutamoren) is an oral ghrelin-mimetic compound often grouped with peptides in discussions, though it is not a peptide chain.
- Where are MK-677 reports?
- See the MK-677 peptide hub.
- Does this page give dosing, prices or sourcing?
- No. We never publish dosing, prices or sourcing, and nothing here is medical advice.
- Does MK-677 increase testosterone?
- Not directly. MK-677 stimulates GH and IGF-1 release but does not act on the HPG axis or androgen receptors. Community accounts do not describe meaningful testosterone increases from MK-677 alone. The body composition improvements accounts describe are GH-mediated — lean mass preservation, improved recovery, reduced fat accumulation — not androgen-driven. Users seeking testosterone support need compounds that act on the HPG axis directly: gonadorelin, enclomiphene, or kisspeptin.
- What does MK-677 feel like the first week?
- Reports are consistent on the first week: deep, vivid sleep within days, increased hunger, and morning facial puffiness. Some describe mild lethargy. Visible changes, if any, come later.
- Can women use MK-677?
- Reports from women describe the same sleep benefits and the same water retention, hunger and puffiness as others, and more side effects at amounts others tolerate. MK-677 is not approved, and there is no safety data in pregnancy. This site does not publish doses.
- Is MK-677 a steroid?
- No. MK-677 is a growth-hormone secretagogue acting on the ghrelin receptor. It does not act on androgen receptors and is not expected to suppress testosterone. It is discussed alongside SARMs and steroids, but its mechanism and side effects — hunger, fluid retention, insulin resistance — are different.
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.